Watchlist
Paper Trade
Screener
Heat Map
Institutional
Tracker

RNAC Cartesian Therapeutics

Watchlist

16.050
+0.120+0.75%

Close Mar 21 16:00 ET

16.050
0.0000.00%

Post 20:01 ET

415.81MMarket Cap-3.57P/E (TTM)

16.790High15.800Low125.43KVolume16.370Open15.930Pre Close2.04MTurnover1.31%Turnover RatioLossP/E (Static)25.91MShares41.87052wk High-61.03P/B153.27MFloat Cap11.66552wk Low--Dividend TTM9.55MShs Float728.003Historical High--Div YieldTTM6.22%Amplitude11.665Historical Low16.241Avg Price1Lot Size

Overview Options Financials Company News Comments

Cartesian Therapeutics News

News

Announcement

Ratings

All

Earnings

Transactions

Shareholding

Events

Other

Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SPRINGER TIMOTHY A
Mar 20 19:50 ET
Cartesian Therapeutics | 10-K: FY2024 Annual Report
Mar 13 07:07 ET
Cartesian Therapeutics | 8-K: Current report
Mar 13 07:04 ET
Cartesian Therapeutics | 8-K: Current report
Mar 3 06:59 ET
Cartesian Therapeutics | SCHEDULE 13G/A: Others
Feb 12 09:31 ET
Cartesian Therapeutics | 8-K: Current report
Jan 27 07:09 ET
Cartesian Therapeutics | SCHEDULE 13D/A: Others
Jan 15 16:28 ET
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SPRINGER TIMOTHY A
Jan 15 16:13 ET
Cartesian Therapeutics | EFFECT: Others
Jan 14 06:03 ET
Cartesian Therapeutics | EFFECT: Others
Jan 14 06:03 ET
Cartesian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jewell Christopher M
Jan 13 16:13 ET
Cartesian Therapeutics | 8-K: Current report
Jan 13 07:28 ET
Cartesian Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Jan 10 06:08 ET
Cartesian Therapeutics | EFFECT: Others
Jan 10 06:06 ET
Cartesian Therapeutics | EFFECT: Others
Jan 10 06:06 ET
Cartesian Therapeutics | EFFECT: Others
Jan 10 06:06 ET
Cartesian Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Jan 10 06:05 ET
Cartesian Therapeutics | 424B7: Prospectus
Jan 8 16:40 ET
Cartesian Therapeutics | 424B7: Prospectus
Jan 8 16:36 ET
Cartesian Therapeutics | 424B3: Prospectus
Jan 8 16:35 ET

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price

Latest News

Carney: Trump Wants to Break US so America Can Own US

00:43

Carney: U.S. President Trump's Unjustified Tariffs and Trade Actions Create 'most Significant Crisis of Our Lifetimes'

00:37

Canadian Prime Minister Carney Proposes Middle Tax Cut, Reducing Lowest Tax Bracket by 1%

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term

Stocks & Industries to Watch Under Trump's Second Presidency

With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?

🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More

Moo Live

Jan 23 16:54

MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.